Physician profile
Aimee Abell
NPI 1720470305
$695.89
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $102 · 2022: $55.02 · 2023: $197 · 2024: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $539.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $130.37 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $115.76 | 2021-2024 | |
| Amgen INC. | $107.03 | 2021-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $89.23 | 2021-2024 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.29 | 2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.00 | 2023 | Lifevest |
| Boston Scientific Corporation | $37.89 | 2023-2024 | Wavewriter Alpha Prime 16, Resolution 360 Ultra Clip |
| Merck Sharp & Dohme LLC | $36.52 | 2023-2024 | Verquvo |
| Pfizer INC. | $21.75 | 2024 | |
| Hologic Sales and Service, LLC | $21.05 | 2024 | Novasure |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Abell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.